324 related articles for article (PubMed ID: 10066958)
1. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone.
Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R
Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958
[TBL] [Abstract][Full Text] [Related]
2. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
3. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
4. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
7. Alopecia areata in children: treatment with diphencyprone.
Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
[TBL] [Abstract][Full Text] [Related]
8. DPCP for the treatment of alopecia areata.
Bolduc C; Shapiro J
Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
[TBL] [Abstract][Full Text] [Related]
9. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
10. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
11. Predictive model for immunotherapy of alopecia areata with diphencyprone.
Wiseman MC; Shapiro J; MacDonald N; Lui H
Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099
[TBL] [Abstract][Full Text] [Related]
12. Topical and intralesional therapies for alopecia areata.
Alkhalifah A
Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
[TBL] [Abstract][Full Text] [Related]
13. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
14. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata.
Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801
[TBL] [Abstract][Full Text] [Related]
15. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic features of alopecia areata: a new look.
Whiting DA
Arch Dermatol; 2003 Dec; 139(12):1555-9. PubMed ID: 14676070
[TBL] [Abstract][Full Text] [Related]
18. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates.
Peckham SJ; Sloan SB; Elston DM
J Am Acad Dermatol; 2011 Sep; 65(3):615-620. PubMed ID: 21684037
[TBL] [Abstract][Full Text] [Related]
19. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
Ohlmeier MC; Traupe H; Luger TA; Böhm M
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
[TBL] [Abstract][Full Text] [Related]
20. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
